Aveanna Healthcare Holdings, Inc. AVAH
We take great care to ensure that the data presented and summarized in this overview for Aveanna Healthcare Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AVAH
View all-
Bain Capital Investors LLC Boston, MA81.6MShares$471 Million13.94% of portfolio
-
J.H. Whitney Equity Partners Vii, LLC48.7MShares$281 Million100.0% of portfolio
-
Nut Tree Capital Management, LP New York, NY12.4MShares$71.4 Million17.74% of portfolio
-
Littlejohn & CO LLC8.11MShares$46.8 Million17.16% of portfolio
-
King Street Capital Management, L.P. New York, NY6.4MShares$36.9 Million29.45% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$20.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$16.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.4MShares$8.08 Million0.0% of portfolio
-
State Street Corp Boston, MA1.04MShares$6 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA1.01MShares$5.84 Million0.0% of portfolio
Latest Institutional Activity in AVAH
Top Purchases
Top Sells
About AVAH
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Insider Transactions at AVAH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 01
2024
|
Brent D Layton |
BUY
Grant, award, or other acquisition
|
Direct |
7,081
+50.0%
|
-
|
Apr 29
2024
|
Jerry Perchik |
BUY
Grant, award, or other acquisition
|
Direct |
162,500
+50.0%
|
-
|
Feb 21
2024
|
Deborah Stewart SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,680
+20.97%
|
-
|
Feb 21
2024
|
Matthew Buckhalter Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
149,897
+31.14%
|
-
|
Feb 21
2024
|
Edwin C. Reisz Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
124,482
+9.34%
|
-
|
Feb 21
2024
|
Rodney D Windley |
BUY
Grant, award, or other acquisition
|
Direct |
62,241
+2.91%
|
-
|
Feb 21
2024
|
Victor F Ganzi |
BUY
Grant, award, or other acquisition
|
Direct |
53,942
+10.59%
|
-
|
Feb 21
2024
|
Patrick A. Cunningham Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,568
+15.81%
|
-
|
Feb 21
2024
|
Richard C Zoretic |
BUY
Grant, award, or other acquisition
|
Direct |
53,942
+17.76%
|
-
|
Feb 21
2024
|
Jeff Shaner |
BUY
Grant, award, or other acquisition
|
Direct |
518,154
+19.28%
|
-
|
Feb 21
2024
|
Erica Schwartz |
BUY
Grant, award, or other acquisition
|
Direct |
53,942
+19.05%
|
-
|
Feb 21
2024
|
Sheldon M Retchin |
BUY
Grant, award, or other acquisition
|
Direct |
53,942
+15.39%
|
-
|
Feb 21
2024
|
Steven E Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
53,942
+16.9%
|
-
|
Feb 14
2024
|
Steven E Rodgers |
BUY
Exercise of conversion of derivative security
|
Direct |
103,175
+32.81%
|
-
|
Feb 14
2024
|
Sheldon M Retchin |
BUY
Exercise of conversion of derivative security
|
Direct |
103,175
+29.84%
|
-
|
Feb 14
2024
|
Richard C Zoretic |
BUY
Exercise of conversion of derivative security
|
Direct |
103,175
+34.51%
|
-
|
Feb 14
2024
|
Victor F Ganzi |
BUY
Exercise of conversion of derivative security
|
Direct |
103,175
+20.45%
|
-
|
Feb 14
2024
|
Erica Schwartz |
BUY
Exercise of conversion of derivative security
|
Direct |
103,175
+37.05%
|
-
|
Feb 14
2024
|
Rodney D Windley |
BUY
Exercise of conversion of derivative security
|
Direct |
119,048
+5.57%
|
-
|
Aug 15
2023
|
Erica Schwartz |
BUY
Exercise of conversion of derivative security
|
Direct |
61,611
+46.07%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 1.38M shares |
---|---|
Exercise of conversion of derivative security | 635K shares |